Transcatheter Mitral Valve Implantation with the Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System

Mitral regurgitation is the most prevalent yet undertreated valvulopathy despite its adverse prognosis. With the emergence of transcatheter mitral interventions, the potential for this huge unmet disease burden to be addressed may finally be realized. Medtronic Intrepid™ Transcatheter Mitral Valve R...

Full description

Saved in:
Bibliographic Details
Published in:Future cardiology 2019-07, Vol.15 (4), p.281-293
Main Authors: Koh, Ji QS, Walton, Antony, Marasco, Silvana, Duffy, Stephen J
Format: Article
Language:English
Subjects:
Beta blockers
Cardiology
Catheters
Heart failure
Intervention
Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System
mitral regurgitation
Mortality
National libraries
Surgery
transcatheter mitral valve implantation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mitral regurgitation is the most prevalent yet undertreated valvulopathy despite its adverse prognosis. With the emergence of transcatheter mitral interventions, the potential for this huge unmet disease burden to be addressed may finally be realized. Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System represents one of several novel solutions. Based on early data from the pilot study, its efficacy and clinical utility is currently being tested against the mainstay treatment of surgical mitral valve replacement in a randomized trial. While there remain significant challenges before transcatheter mitral intervention can become part of the routine treatment algorithm, the authors are optimistic that transcatheter mitral valve repair and intervention have the potential in revolutionizing the management of severe symptomatic mitral regurgitation.
ISSN:1479-6678
1744-8298
DOI:10.2217/fca-2018-0082